Form 4 holding
Chief Financial Officer
Oncology Institute, Inc.
- Security class
- Common Stock
- Shares / value
- 414,801
- Estimated value
- $1,273,439
- Report date
- 21 May 2026
- Price
- $3.07
- Ownership
- Direct
Robert Ross Carter
Insider Reports History
- Reporting-owner location
- Cerritos, CA
- Latest reporting-owner signature
-
/s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Robert Ross Carter
Form 4 holding
Chief Financial Officer
Oncology Institute, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 235,174
- Estimated value
- $629,090
- Report date
- 21 May 2025
- Price
- $2.68
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Oncology Institute, Inc.
- Security class
- Common Warrant
- Shares / value
- 4,528
- Estimated value
- $566
- Report date
- 26 Mar 2025
- Price
- $0.1250
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Robert Ross Carter
4
TOI
Oncology Institute, Inc.
- Report period
- 21 May 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 22 May 2026, 17:32
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
TOI
Oncology Institute, Inc.
- Report period
- 27 Mar 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 01 Apr 2026, 20:47
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
TOI
Oncology Institute, Inc.
- Report period
- 17 Mar 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 18 Mar 2026, 17:20
- Role
- Chief Financial Officer
- Next action
- Open filing details
4/A
TOI
Oncology Institute, Inc.
- Report period
- 02 Jan 2026
- Transactions
- 1
- Transaction value
- -$895
- Accepted by SEC
- 06 Jan 2026, 16:30
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
TOI
Oncology Institute, Inc.
- Report period
- 17 Nov 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 19 Nov 2025, 18:00
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
TOI
Oncology Institute, Inc.
- Report period
- 21 May 2025
- Transactions
- 1
- Transaction value
- -$4,283
- Accepted by SEC
- 22 May 2025, 14:12
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
TOI
Oncology Institute, Inc.
- Report period
- 31 Mar 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 02 Apr 2025, 17:22
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
TOI
Oncology Institute, Inc.
- Report period
- 26 Mar 2025
- Transactions
- 2
- Transaction value
- +$10,000
- Accepted by SEC
- 28 Mar 2025, 17:27
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
TOI
Oncology Institute, Inc.
- Report period
- 19 Mar 2025
- Transactions
- 1
- Transaction value
- -$1,022
- Accepted by SEC
- 20 Mar 2025, 17:56
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
TOI
Oncology Institute, Inc.
- Report period
- 06 Jan 2025
- Transactions
- 1
- Transaction value
- -$86.43
- Accepted by SEC
- 07 Jan 2025, 13:18
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
TOI
Oncology Institute, Inc.
- Report period
- 20 Nov 2024
- Transactions
- 1
- Transaction value
- -$31.96
- Accepted by SEC
- 21 Nov 2024, 18:21
- Role
- Chief Financial Officer
- Next action
- Open filing details
3
TOI
Oncology Institute, Inc.
- Report period
- 20 Sep 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 30 Sep 2024, 16:30
- Role
- Chief Financial Officer
- Next action
- Open filing details